Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Shervin Shokouhi and Omid Moradi.
Shervin Shokouhi
Connection Strength
0.232
Omid Moradi
  1. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial. Int Immunopharmacol. 2021 Oct; 99:107969.
    View in: PubMed
    Score: 0.060
  2. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial. Int Immunopharmacol. 2021 Oct; 99:107916.
    View in: PubMed
    Score: 0.060
  3. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial. Trials. 2020 Oct 26; 21(1):880.
    View in: PubMed
    Score: 0.057
  4. Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion. J Med Virol. 2021 01; 93(1):69-70.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.